annual current liabilities:
$292.40M+$2.20M(+0.76%)Summary
- As of today (May 29, 2025), SUPN annual total current liabilities is $292.40 million, with the most recent change of +$2.20 million (+0.76%) on December 31, 2024.
- During the last 3 years, SUPN annual current liabilities has fallen by -$22.98 million (-7.29%).
- SUPN annual current liabilities is now -57.50% below its all-time high of $687.96 million, reached on December 31, 2022.
Performance
SUPN Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$281.77M-$10.63M(-3.63%)Summary
- As of today (May 29, 2025), SUPN quarterly total current liabilities is $281.77 million, with the most recent change of -$10.63 million (-3.63%) on March 31, 2025.
- Over the past year, SUPN quarterly current liabilities has dropped by -$32.78 million (-10.42%).
- SUPN quarterly current liabilities is now -61.69% below its all-time high of $735.54 million, reached on June 30, 2022.
Performance
SUPN quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
SUPN Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.8% | -10.4% |
| 3 y3 years | -7.3% | -1.0% |
| 5 y5 years | +82.1% | +67.4% |
SUPN Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -57.5% | +0.8% | -61.7% | +11.6% |
| 5 y | 5-year | -57.5% | +82.1% | -61.7% | +67.4% |
| alltime | all time | -57.5% | +3433.9% | -61.7% | +2708.4% |
SUPN Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $281.77M(-3.6%) |
| Dec 2024 | $292.40M(+0.8%) | $292.40M(+0.3%) |
| Sep 2024 | - | $291.51M(-5.6%) |
| Jun 2024 | - | $308.66M(-1.9%) |
| Mar 2024 | - | $314.55M(+8.4%) |
| Dec 2023 | $290.20M(-57.8%) | $290.20M(+0.9%) |
| Sep 2023 | - | $287.53M(+13.8%) |
| Jun 2023 | - | $252.59M(-65.5%) |
| Mar 2023 | - | $731.54M(+6.3%) |
| Dec 2022 | $687.96M(+118.1%) | $687.96M(-5.2%) |
| Sep 2022 | - | $725.99M(-1.3%) |
| Jun 2022 | - | $735.54M(+158.5%) |
| Mar 2022 | - | $284.56M(-9.8%) |
| Dec 2021 | $315.38M(+28.7%) | $315.38M(+34.4%) |
| Sep 2021 | - | $234.71M(-17.2%) |
| Jun 2021 | - | $283.45M(+17.7%) |
| Mar 2021 | - | $240.81M(-1.8%) |
| Dec 2020 | $245.11M(+52.6%) | $245.11M(-18.2%) |
| Sep 2020 | - | $299.61M(+11.3%) |
| Jun 2020 | - | $269.28M(+60.0%) |
| Mar 2020 | - | $168.34M(+4.8%) |
| Dec 2019 | $160.59M(-0.5%) | $160.59M(+7.3%) |
| Sep 2019 | - | $149.72M(+4.0%) |
| Jun 2019 | - | $143.97M(-5.1%) |
| Mar 2019 | - | $151.71M(-6.0%) |
| Dec 2018 | $161.35M(+31.2%) | $161.35M(+16.6%) |
| Sep 2018 | - | $138.35M(+33.1%) |
| Jun 2018 | - | $103.93M(-12.7%) |
| Mar 2018 | - | $119.09M(-3.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $123.00M(+52.3%) | $123.00M(+17.2%) |
| Sep 2017 | - | $104.96M(+22.7%) |
| Jun 2017 | - | $85.52M(+4.3%) |
| Mar 2017 | - | $82.00M(+1.6%) |
| Dec 2016 | $80.74M(+41.8%) | $80.74M(+12.7%) |
| Sep 2016 | - | $71.65M(+9.3%) |
| Jun 2016 | - | $65.57M(+21.2%) |
| Mar 2016 | - | $54.12M(-4.9%) |
| Dec 2015 | $56.93M(+102.4%) | $56.93M(+32.0%) |
| Sep 2015 | - | $43.13M(+18.4%) |
| Jun 2015 | - | $36.41M(+35.6%) |
| Mar 2015 | - | $26.86M(-4.5%) |
| Dec 2014 | $28.12M(+6.5%) | $28.12M(+27.1%) |
| Sep 2014 | - | $22.13M(+15.3%) |
| Jun 2014 | - | $19.19M(-29.2%) |
| Mar 2014 | - | $27.10M(+2.7%) |
| Dec 2013 | $26.40M(+14.9%) | $26.40M(+5.3%) |
| Sep 2013 | - | $25.07M(+56.5%) |
| Jun 2013 | - | $16.02M(-40.7%) |
| Mar 2013 | - | $27.01M(+17.5%) |
| Dec 2012 | $22.98M(+22.4%) | $22.98M(-6.5%) |
| Sep 2012 | - | $24.59M(+12.4%) |
| Jun 2012 | - | $21.88M(+9.9%) |
| Mar 2012 | - | $19.91M(+6.1%) |
| Dec 2011 | $18.77M(+23.4%) | $18.77M(+13.7%) |
| Sep 2011 | - | $16.51M(+8.6%) |
| Dec 2010 | $15.21M(+51.6%) | $15.21M(-12.6%) |
| Sep 2010 | - | $17.41M(+73.5%) |
| Dec 2009 | $10.03M(+21.3%) | $10.03M |
| Dec 2008 | $8.27M | - |
FAQ
- What is Supernus Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual current liabilities year-on-year change?
- What is Supernus Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly current liabilities year-on-year change?
What is Supernus Pharmaceuticals annual total current liabilities?
The current annual current liabilities of SUPN is $292.40M
What is the all time high annual current liabilities for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual total current liabilities is $687.96M
What is Supernus Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, SUPN annual total current liabilities has changed by +$2.20M (+0.76%)
What is Supernus Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of SUPN is $281.77M
What is the all time high quarterly current liabilities for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly total current liabilities is $735.54M
What is Supernus Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, SUPN quarterly total current liabilities has changed by -$32.78M (-10.42%)